Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
19m agoGameStop Proposes to Acquire eBay at $125.00 Per Share
46m agoXtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
46m agoApplied Materials Broadens Advanced Packaging Portfolio with Acquisition of NEXX
1h agoFaraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: EAI Robotics Sales Momentum Continues Along with University Collaborations and Partnership Development
2h ago$9 Trillion Is Pouring Into American Manufacturing — And It’s Just Getting Started
Marker Therapeutics, Inc. logo

Marker Therapeutics, Inc.

About

Marker Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 18 2026
Marker Therapeutics Reports Year-End 2025 Corporate and Financial Results
Feb 18 2026
Marker Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Jan 26 2026
Good Morning America Features Baylor College of Medicine Pancreatic Cancer Study Utilizing Marker Therapeutics’ MAR-T Cell Technology
Jan 5 2026
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer
Nov 14 2025
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Case study
How Marker Therapeutics, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Community Chat

Ask AI

6ix6ix